Table of Content

Open Access iconOpen Access

ARTICLE

MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide

Zhiguo Wang*†1, Zehui Fang‡1, Runzhang Lu, Hongli Zhao, Tiejun Gong, Dong Liu, Luojia Hong, Jun Ma, Mei Zhang*

* Department of Hematology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shanxi Province, P.R. China
† Department of Bone Marrow Transplantation, Harbin Hematological Cancer Institute, Harbin the First Hospital, Harbin Province, P.R. China
‡ Department of Endocrinology, the 4th Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, P.R. China

Oncology Research 2019, 27(9), 1035-1042. https://doi.org/10.3727/096504019X15528367532612

Abstract

Although arsenic trioxide (ATO) is a well-known antileukemic drug used for acute promyelocytic leukemia treatment, the development of ATO resistance is still a big challenge. We previously reported that microRNA- 204 (miR-204) was involved in the regulation of acute myeloid leukemia (AML) cell apoptosis, but its role in chemoresistance is poorly understood. In the present study, we showed that miR-204 was significantly increased in AML cells after ATO treatment. Interestingly, the increased miR-204 level that was negatively correlated with ATO induced the decrease in cell viability and baculoviral inhibition of apoptosis protein repeatcontaining 6 (BIRC6) expression. Overexpression of miR-204 potentiated ATO-induced AML cell growth inhibition and apoptosis. Furthermore, miR-204 directly targets to the 3 -UTR of BIRC6. Upregulation of miR-204 decreased BIRC6 luciferase activity and expression, which subsequently enhanced the expression of p53. Restoration of BIRC6 markedly reversed the effect of miR-204 on the regulation of AML cell sensitivity to ATO. Taken together, our study demonstrates that miR-204 decreases ATO chemoresistance in AML cells at least partially via promoting BIRC6/p53-mediated apoptosis. miR-204 represents a novel target of ATO, and upregulation of miR-204 may be a useful strategy to improve the efficacy of ATO in AML treatment.

Keywords


Cite This Article

APA Style
Wang, Z., Fang, .Z., Lu, .R., Zhao, H., Gong, T. et al. (2019). Microrna-204 potentiates the sensitivity of acute myeloid leukemia cells to arsenic trioxide. Oncology Research, 27(9), 1035-1042. https://doi.org/10.3727/096504019X15528367532612
Vancouver Style
Wang Z, Fang Z, Lu R, Zhao H, Gong T, Liu , et al. Microrna-204 potentiates the sensitivity of acute myeloid leukemia cells to arsenic trioxide. Oncol Res. 2019;27(9):1035-1042 https://doi.org/10.3727/096504019X15528367532612
IEEE Style
Z. Wang et al., "MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide," Oncol. Res., vol. 27, no. 9, pp. 1035-1042. 2019. https://doi.org/10.3727/096504019X15528367532612



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 524

    View

  • 455

    Download

  • 0

    Like

Share Link